8.54 USD
-0.01 (-0.12%)
8.54 USD
0 (0%)
Overall CMRX gets a fundamental rating of 4 out of 10. We evaluated CMRX against 525 industry peers in the Biotechnology industry. CMRX has a great financial health rating, but its profitability evaluates not so good. CMRX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CMRX had negative earnings in the past year.
- In the past year CMRX has reported a negative cash flow from operations.
- CMRX had negative earnings in 4 of the past 5 years.
- In the past 5 years CMRX always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of CMRX (-60.54%) is worse than 60.49% of its industry peers.
- The Return On Equity of CMRX (-72.64%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -60.54% | ||
| ROE | -72.64% | ||
| ROIC | N/A |
ROA(3y)-12.49%
ROA(5y)-52.25%
ROE(3y)-16.05%
ROE(5y)-72.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 100.00%, CMRX belongs to the best of the industry, outperforming 99.12% of the companies in the same industry.
- CMRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 100% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CMRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, CMRX has more shares outstanding
- Compared to 5 years ago, CMRX has more shares outstanding
- There is no outstanding debt for CMRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 10.02 indicates that CMRX is not in any danger for bankruptcy at the moment.
- CMRX has a better Altman-Z score (10.02) than 88.54% of its industry peers.
- There is no outstanding debt for CMRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 10.02 |
ROIC/WACCN/A
WACC10.2%
2.3 Liquidity
- A Current Ratio of 5.70 indicates that CMRX has no problem at all paying its short term obligations.
- With a decent Current ratio value of 5.70, CMRX is doing good in the industry, outperforming 61.55% of the companies in the same industry.
- CMRX has a Quick Ratio of 5.70. This indicates that CMRX is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of CMRX (5.70) is better than 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.7 | ||
| Quick Ratio | 5.7 |
3. Growth
3.1 Past
- The earnings per share for CMRX have decreased by -7.61% in the last year.
- CMRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.57%.
- The Revenue for CMRX have been decreasing by -55.77% on average. This is quite bad
EPS 1Y (TTM)-7.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y-52.51%
Revenue growth 5Y-55.77%
Sales Q2Q%1325%
3.2 Future
- CMRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.51% yearly.
- CMRX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 381.56% yearly.
EPS Next Y13.8%
EPS Next 2Y5.53%
EPS Next 3Y24.46%
EPS Next 5Y27.51%
Revenue Next Year2198.64%
Revenue Next 2Y1434.15%
Revenue Next 3Y731.43%
Revenue Next 5Y381.56%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CMRX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMRX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- CMRX's earnings are expected to grow with 24.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.53%
EPS Next 3Y24.46%
5. Dividend
5.1 Amount
- No dividends for CMRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CHIMERIX INC / CMRX FAQ
Can you provide the ChartMill fundamental rating for CHIMERIX INC?
ChartMill assigns a fundamental rating of 4 / 10 to CMRX.
What is the valuation status of CHIMERIX INC (CMRX) stock?
ChartMill assigns a valuation rating of 1 / 10 to CHIMERIX INC (CMRX). This can be considered as Overvalued.
How profitable is CHIMERIX INC (CMRX) stock?
CHIMERIX INC (CMRX) has a profitability rating of 1 / 10.
What is the expected EPS growth for CHIMERIX INC (CMRX) stock?
The Earnings per Share (EPS) of CHIMERIX INC (CMRX) is expected to grow by 13.8% in the next year.